TIL NASDAQ
Instil Bio, Inc.
1W: +0.7%
1M: -6.1%
3M: -6.5%
YTD: -35.9%
1Y: -62.2%
3Y: -12.4%
5Y: -98.4%
$7.22
-0.01 (-0.21%)
Weekly Expected Move ±3.8%
$7
$7
$7
$7
$8
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$49.0M
52W Range5.67-21.98
Volume28,551
Avg Volume13,342
Beta1.92
Dividend—
Analyst Ratings
Company Info
CEOBronson Crouch
Employees17
SectorHealthcare
IndustryBiotechnology
IPO Date2021-03-19
Websiteinstilbio.com
3963 Maple Avenue
Dallas, TX 75219
US
Dallas, TX 75219
US
972 499 3350
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Latest News
Instil Bio Reports Second Quarter 2026 Financial Results and Provides Corporate Update
12 Health Care Stocks Moving In Wednesday's After-Market Session
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Instil Bio, Inc. Investigated by the Portnoy Law Firm
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| McGaughy R Kent Jr | A-Award | 6,500 | $7.93 | 2026-06-11 |
| Matcham George | A-Award | 6,500 | $7.93 | 2026-06-11 |
| Gibson Neil W | A-Award | 0 | $7.93 | 2026-06-11 |
| Binder Gwendolyn | A-Award | 6,500 | $7.93 | 2026-06-11 |
| Laumas Sandeep | M-Exempt | 13,000 | $12.68 | 2025-09-10 |